Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Diazepam Spray for Termination of Generalized Convulsive Status Epilepticus
ChiCTR2500101766Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of diazepam in Generalized Convulsive Status Epilepticus (GCSE), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Proportion of seizures terminated within 10 minutes of medication. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
diazepam
03
Conditions
Generalized Convulsive Status Epilepticus (GCSE)
Beyond the preview
Go deeper on ChiCTR2500101766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101766.